A novel sustained-release 5-fluorouracil (5-FU) implant showed promise for glaucoma surgery. The implant helped control intraocular pressure in most high-risk patients without adverse events.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: